| Literature DB >> 34476476 |
Arja Heliövaara1, Annelise Küseler2, Pål Skaare3, Haydn Bellardie4,5, Kirsten Mølsted6, Agneta Karsten7, Agneta Marcusson8, Sara Rizell9, Eli Brinck3, Paul Sæle10, Midia Najar Chalien9, Jeanette Mooney4, Phil Eyres4, William Shaw4, Gunvor Semb3,4.
Abstract
BACKGROUND AND TRIALEntities:
Mesh:
Year: 2022 PMID: 34476476 PMCID: PMC9127717 DOI: 10.1093/ejo/cjab055
Source DB: PubMed Journal: Eur J Orthod ISSN: 0141-5387 Impact factor: 3.131
Figure 1.Flow charts of the three Scandcleft trials.
Figure 2.Sequence of closure of unilateral cleft lip and palate (UCLP). The figure and text are reprinted with permission from Rautio et al. (2017), Journal of Plastic Surgery and Hand Surgery, Taylor & Francis. The first operation is indicated by the red line and the second operation by the blue line. In the common method (Arm A), the lip was repaired simultaneously with soft palate closure at 3–4 months, followed by hard palate closure at 12 months. In Trial 1, the common method (Arm A) was compared with hard palate closure delayed until 3 years of age (Arm B). In Trial 2, the common method (Arm A) was compared with closure of the lip at 3–4 months, followed by closure of the hard and soft palate together at 12 months (Arm C). In Trial 3, the common method (Arm A) was compared with lip and hard palate closure at 3–4 months, followed by soft palate closure at 12 months (Arm D).
Number, gender, and age (years) of patients in the three trials with four surgical methods (Arms A, B, C, and D) at 5, 8, and 10 years of age.
| Trial | Children (boys/girls) | Mean age (range) | Arm A | Arms B or C or D | |
|---|---|---|---|---|---|
| Age 5 years | Trial 1 (A, B) | 142 (96/46) | 5.1 (4.8–7.0) | 74 | 68 |
| Trial 2 (A, C) | 142 (94/48) | 5.1 (4.8–6.6) | 69 | 73 | |
| Trial 3 (A, D) | 134 (83/51) | 5.3 (4.9–6.9) | 64 | 70 | |
| Total | 418 (273/145) | 5.1 (4.8–7.0) | 207 | 211 | |
| Age 8 years | Trial 1 (A, B) | 145 (99/46) | 8.1 (7.5–9.2) | 72 | 73 |
| Trial 2 (A, C) | 136 (89/47) | 8.1 (7.4–10.0) | 67 | 69 | |
| Trial 3 (A, D) | 130 (82/48) | 8.2 (7.0–9.3) | 61 | 69 | |
| Total | 411 (270/141) | 8.1 (7.0–10.0) | 200 | 211 | |
| Age 10 years | Trial 1 (A, B) | 142 (96/46) | 10.1 (9.6–11.2) | 71 | 71 |
| Trial 2 (A, C) | 142 (94/48) | 10.1 (9.2–11.1) | 68 | 74 | |
| Trial 3 (A, D) | 126 (77/49) | 10.2 (9.9–11.5) | 62 | 64 | |
| Total | 410 (267/143) | 10.1 (9.2–11.5) | 201 | 209 |
Figure 3.Photographs of examples of the models used for reference of palatal morphology of the Eurocran index scores from grade 1 to 3. Palatal morphology according to the Eurocran index (12). 1. Good anterior and posterior height; minor surface irregularities (bumps and crevices); no or minor deviation of arch form. 2. Moderate anterior and posterior height; moderate surface irregularities (bumps and crevices); moderate deviation of arch form (e.g. segmental displacement). 3. Severe reduction in palate height; severe surface irregularities (bumps and crevices); severe deviation in arch form (e.g. ‘hourglass’ constriction). The worst feature of the three suggests the initial score. This may be modified up or down depending on how good the other features are. If good arch form was achieved by means of orthodontic treatment, the case is graded lower.
Index comparisons of the intra- and inter-rater reliabilities at 5, 8, and 10 years of age.
| Intra-rater | Inter-rater | |
|---|---|---|
| Age 5 years | ||
| Eurocran dental arch relationships | 0.71–0.97 | 0.72–0.92 |
| Eurocran palatal index | 0.30–1.00 | 0.26–0.56 |
| 5-Year-olds’ (5Y0) index | 0.71–0.94 | 0.70–0.87 |
| Age 8 years | ||
| Eurocran dental arch relationships | 0.81–0.95 | 0.72–0.80 |
| GOSLON Yardstick | 0.62–0.89 | 0.60–0.80 |
| Age 10 years | ||
| Eurocran dental arch relationships | 0.71–1.0 | 0.52–0.85 |
| GOSLON Yardstick | 0.57–0.89 | 0.43–0.71 |
Distribution and significance of t-test of the mean dental index scores over surgical methods (Arms A, B, C, and D) within trials.
| Eurocran index | |||||||
|---|---|---|---|---|---|---|---|
| Trial | Mean index score |
| Standard deviation | Range of mean score |
|
| |
| Age 5 years | Trial 1 | A 2.59 | 74 | 0.97 | 1.00–4.00 | A vs B | 0.14 ns |
| B 2.36 | 68 | 0.91 | 1.00–4.00 | ||||
| Trial 2 | A 2.47 | 69 | 0.98 | 1.00–4.00 | A vs C | 0.28 ns | |
| C 2.29 | 73 | 0.96 | 1.00–4.00 | ||||
| Trial 3 | A 2.67 | 64 | 1.0 | 1.06–4.00 | A vs D | 0.90 ns | |
| D 2.65 | 70 | 0.91 | 1.00–4.00 | ||||
| All Trials 1, 2, 3 | A, B, C, D 2.50 | 418 | 0.96 | 1.00–4.00 | |||
| Age 8 years | Trial 1 | A 2.73 | 72 | 0.81 | 1.00–4.00 | A vs B | 0.146 ns |
| B 2.53 | 73 | 0.87 | 1.00–4.00 | ||||
| Trial 2 | A 2.48 | 67 | 0.94 | 1.00–4.00 | A vs C | 0.303 ns | |
| C 2.33 | 69 | 0.86 | 1.00–4.00 | ||||
| Trial 3 | A 2.77 | 61 | 0.86 | 1.14–4.00 | A vs D | 0.897 ns | |
| D 2.75 | 69 | 0.81 | 1.00–4.00 | ||||
| All Trials 1, 2, 3 | A, B, C, D 2.60 | 411 | 0.87 | 1.00–4.00 | |||
| Age 10 years | Trial 1 | A 2.21 | 71 | 0.94 | 1.00–4.00 | A vs B | 0.21 ns |
| B 2.02 | 71 | 0.92 | 1.00–4.00 | ||||
| Trial 2 | A 2.30 | 68 | 1.01 | 1.08–4.00 | A vs C | 0.06 ns | |
| C 1.99 | 74 | 0.94 | 1.00–4.00 | ||||
| Trial 3 | A 2.51 | 62 | 1.04 | 1.00–4.00 | A vs D | 0.53 ns | |
| D 2.62 | 64 | 0.98 | 1.08–4.00 | ||||
| All Trials 1, 2, 3 | A, B, C, D 2.26 | 410 | 0.99 | 1.00–4.00 | |||
| 5-year-olds' (5YO) index (at age 5 years) and GOSLON Yardstick scores (at age 8 and 10 years) | |||||||
| Trial | Mean index score |
| Standard deviation | Range of mean score |
|
| |
| Age 5 years* | Trial 1 | A 2.86 | 74 | 0.94 | 1.06–4.88 | A vs B | 0.06 ns |
| B 2.58 | 68 | 0.87 | 1.00–4.31 | ||||
| Trial 2 | A 2.78 | 69 | 0.95 | 1.06–4.88 | A vs C | 0.11 ns | |
| C 2.52 | 73 | 0.94 | 1.00–4.94 | ||||
| Trial 3 | A 2.94 | 64 | 1.04 | 1.31–5.00 | A vs D | 0.92 ns | |
| D 2.92 | 70 | 0.91 | 1.13–4.88 | ||||
| All Trials 1, 2, 3 | A, B, C, D 2.77 | 418 | 0.95 | 1.00–5.00 | |||
| Age 8 years** | Trial 1 | A 3.03 | 72 | 0.85 | 1.09–4.82 | A vs B | 0.137 ns |
| B 2.82 | 73 | 0.81 | 1.36–4.82 | ||||
| Trial 2 | A 2.78 | 67 | 0.9 | 1.18–4.91 | A vs C | 0.360 ns | |
| C 2.64 | 69 | 0.91 | 1.00–5.00 | ||||
| Trial 3 | A 3.06 | 61 | 0.9 | 1.09–4.91 | A vs D | 0.850 ns | |
| D 3.08 | 69 | 0.86 | 1.64–5.00 | ||||
| All Trials 1, 2, 3 | A, B, C, D 2.90 | 411 | 0.88 | 1.00–5.00 | |||
| Age 10 years | Trial 1 | A 2.54 | 71 | 0.9 | 1.08–5.00 | A vs B | 0.18 ns |
| B 2.34 | 71 | 0.88 | 1.00–4.92 | ||||
| Trial 2 | A 2.49 | 68 | 1.02 | 1.17–4.50 | A vs C | 0.09 ns | |
| C 2.21 | 74 | 0.98 | 1.08–5.00 | ||||
| Trial 3 | A 2.80 | 62 | 1.08 | 1.25–5.00 | A vs D | 0.45 ns | |
| D 2.94 | 64 | 1.03 | 1.50–5.00 | ||||
| All Trials 1, 2, 3 | A, B, C, D 2.54 | 410 | 1.01 | 1.00–5.00 |
*The data of the 5YO index is published previously in Heliövaara et al. (3).
**The data of the GOSLON Yardstick at age 8 years is published previously in Heliövaara et al. (4).
Significance of t-test of the mean dental index scores over surgical methods (Arms A, B, C, and D) between trials.
| Eurocran index |
|
|
| |||
|---|---|---|---|---|---|---|
| Age 5 years | Arm A | Arm A | Arm A | |||
| Trial 1 vs Trial 2 | 0.464 ns | Trial 1 vs Trial 3 | 0.608 ns | Trial 2 vs Trial 3 | 0.234 ns | |
| Arm B vs Arm C | Arm B vs Arm D | Arm C vs Arm D | ||||
| Trial 1 vs Trial 2 | 0.694 ns | Trial 1 vs Trial 3 | 0.055 ns | Trial 2 vs Trial 3 | 0.022 * | |
| Age 8 years | Arm A | Arm A | Arm A | |||
| Trial 1 vs Trial 2 | 0.095 ns | Trial 1 vs Trial 3 | 0.802 ns | Trial 2 vs Trial 3 | 0.074 ns | |
| Arm B vs Arm C | Arm B vs Arm D | Arm C vs Arm D | ||||
| Trial 1 vs Trial 2 | 0.159 ns | Trial 1 vs Trial 3 | 0.119 ns | Trial 2 vs Trial 3 | 0.003 ** | |
| Age 10 years | Arm A | Arm A | Arm A | |||
| Trial 1 vs Trial 2 | 0.582 ns | Trial 1 vs Trial 3 | 0.088 ns | Trial 2 vs Trial 3 | 0.259 ns | |
| Arm B vs Arm C | Arm B vs Arm D | Arm C vs Arm D | ||||
| Trial 1 vs Trial 2 | 0.841 ns | Trial 1 vs Trial 3 | 0.000 *** | Trial 2 vs Trial 3 | 0.000 *** | |
| 5-Year-olds’ (5YO) index (at age 5 years) and GOSLON Yardstick scores (at age 8 and 10 years) | ||||||
|
|
|
| ||||
| Age 5 years | Arm A | Arm A | Arm A | |||
| Trial 1 vs Trial 2 | 0.599 ns | Trial 1 vs Trial 3 | 0.652 ns | Trial 2 vs Trial 3 | 0.356 ns | |
| Arm B vs Arm C | Arm B vs Arm D | Arm C vs Arm D | ||||
| Trial 1 vs Trial 2 | 0.732 ns | Trial 1 vs Trial 3 | 0.025 * | Trial 2 vs Trial 3 | 0.012 * | |
| Age 8 years | Arm A | Arm A | Arm A | |||
| Trial 1 vs Trial 2 | 0.102 ns | Trial 1 vs Trial 3 | 0.851 ns | Trial 2 vs Trial 3 | 0.088 ns | |
| Arm B vs Arm C | Arm B vs Arm D | Arm C vs Arm D | ||||
| Trial 1 vs Trial 2 | 0.214 ns | Trial 1 vs Trial 3 | 0.061 ns | Trial 2 vs Trial 3 | 0.004 ** | |
| Age 10 years | Arm A | Arm A | Arm A | |||
| Trial 1 vs Trial 2 | 0.757 ns | Trial 1 vs Trial 3 | 0.140 ns | Trial 2 vs Trial 3 | 0.097 ns | |
| Arm B vs Arm C | Arm B vs Arm D | Arm C vs Arm D | ||||
| Trial 1 vs Trial 2 | 0.379 ns | Trial 1 vs Trial 3 | 0.000 *** | Trial 2 vs Trial 3 | 0.000 *** |
*P < 0.05; ** P < 0.01; *** P < 0.001.
Figure 4.Proportions (%) of the mean dental index score distributions of the total sample at 5, 8, and 10 years of age.